Company profile

Royal DSM specializes in the development, manufacture and marketing of performance materials, and nutritional and pharmaceutical ingredients. The products are used in a wide range of end-markets and applications, such as human and animal nutrition and health, personal care, pharmaceuticals, automotive and transport, coatings and paint, housing and electrics & electronics. Net sales (not including sold divisions) by family of products and services break down as follows:
  • nutritional ingredients (64.3%): vitamins, enzymes, carotenoids, food ingredients, benzoates, etc. for the cosmetic, food, and animal nutrition industries;
  • performance materials (32.7%): elastomers, resins, plastics, etc.;
  • biomedical and biotechnological products (2%);
  • other (1%).
Net sales break down geographically as follows: the Netherlands (25.1%), Europe (29.6%), Americas (28.1%), China (10.8%), India (1%), Japan (0.9%), Asia (3 5%) and other (1%).

Source: Cofisem - Last Update: 22 Oct 2019
Key Executives
Chairman of the Executive Board Feike Sijbesma
Chief Financial Officer Geraldine Matchett
Member of the Executive Board de Vreeze Dimitri
Member of the Executive Board Stephan B. Tanda
Communications Herman Betten
Investor Relations Dave Huizing
Source: Cofisem - Last Update: 16 May 2018
Key figures
Millenium 2015 2014 2013 2012 2011
Net sales 8,935,000 9,181,000 9,051,000 9,131,000 9,193,000
Income from ordinary activities 8,935,000 9,181,000 9,051,000 9,131,000 9,193,000
Operating income 304,000 263,000 645,000 441,000 928,000
Cost of net financial indebtedness -141,000 -125,000 -124,000 -90,000 -99,000
Equity-Accounted companies' contribution to results 30,000 59,000 -2,000 2,000 3,000
Net profit from discontinued activities 0 30,000
Net income 92,000 101,000 420,000 298,000 860,000
Net income (group share) 88,000 147,000 420,000 288,000 814,000
Fiscal year end 12.15 12.14 12.13 12.12 12.11
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 22 Oct 2019
Shareholder information
Delta Lloyd 3.00 %
Rabobank Nederland 3.00 %
ASR Nederland 3.00 %
State Street Corporation 2.99 %
Blackrock 2.91 %
Third Point LLC 2.66 %
UBS Group AG 1.05 %
Source: Cofisem - Last Update: 21 Oct 2019

Address

Royal DSM

1 Het Overloon
PO Box 6500
NL-6401 JH Heerlen
Netherlands
Source: Cofisem - Last Update: 22 Oct 2019

Contact

Dave Huizing
Phone number: +31 45 578 2864
Source: Royal DSM - Last Update: 28 Sep 2016